Treatment of autoimmune hepatitis: Budesonide does not solve our problems
Hepatology
.
2023 Apr 1;77(4):1071-1073.
doi: 10.1097/HEP.0000000000000183.
Epub 2023 Feb 3.
Authors
Silja Steinmann
1
,
Ansgar W Lohse
Affiliation
1
1st Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
PMID:
36929765
DOI:
10.1097/HEP.0000000000000183
No abstract available
Publication types
Editorial
Comment
MeSH terms
Azathioprine
Budesonide* / therapeutic use
Hepatitis, Autoimmune* / drug therapy
Humans
Immunosuppressive Agents
Prednisone
Substances
Budesonide
Prednisone
Azathioprine
Immunosuppressive Agents